BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14583580)

  • 1. Cigarette smoking, TB, and TNF inhibitors.
    Bieber J; Kavanaugh A
    Ann Rheum Dis; 2003 Nov; 62(11):1118-9. PubMed ID: 14583580
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
    Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
    JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers.
    Seong SS; Choi CB; Woo JH; Bae KW; Joung CL; Uhm WS; Kim TH; Jun JB; Yoo DH; Lee JT; Bae SC
    J Rheumatol; 2007 Apr; 34(4):706-11. PubMed ID: 17309133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum developing during therapy with TNF-alpha antagonists in a patient with rheumatoid arthritis.
    Vandevyvere K; Luyten FP; Verschueren P; Lories R; Segaert S; Westhovens R
    Clin Rheumatol; 2007 Dec; 26(12):2205-2206. PubMed ID: 17876646
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
    Chan CY; Browning JC; Larsen F; Hsu S
    Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B.
    Doubrawa E; Ricca RA; Malucelli TO; Pizzol VI; Barros DH; Paiva ES
    Rev Bras Reumatol; 2012 Aug; 52(4):653-5. PubMed ID: 22885430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meta analysis of infection risks of anti-TNF-α treatment in rheumatoid arthritis].
    Xie X; Chen J; Peng Y; Gao J; Tian J; Ling G; Du J; Mao N; Wu P; Li F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):722-36. PubMed ID: 23908082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary infections in patients with rheumatoid arthritis who have received anti-TNF therapy.
    Amano K
    Intern Med; 2006; 45(17):991-2. PubMed ID: 17015997
    [No Abstract]   [Full Text] [Related]  

  • 9. Active tuberculosis in a patient with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitor.
    Fuchs I; Abu-Shakra M; Gelfer E; Smoliakov A; Ben-Haroch D; Horowitz J; Avnon LS
    Isr Med Assoc J; 2010 Sep; 12(9):579-81. PubMed ID: 21287806
    [No Abstract]   [Full Text] [Related]  

  • 10. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
    Nagashima T; Minota S
    J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab.
    Fabre S; Gibert C; Lechiche C; Jorgensen C; Sany J
    J Rheumatol; 2005 Dec; 32(12):2432-3. PubMed ID: 16331777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
    Matsumoto T; Tanaka T; Kawase I
    N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
    [No Abstract]   [Full Text] [Related]  

  • 13. Which TNF inhibitor for rheumatoid arthritis?
    Med Lett Drugs Ther; 2010 May; 52(1338):38-9. PubMed ID: 20467356
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour necrosis factor blockade in rheumatoid arthritis.
    Breedveld FC
    Clin Med (Lond); 2001; 1(2):107-9. PubMed ID: 11333452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis].
    Tomono K; Hashimoto S
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():573-8. PubMed ID: 15799420
    [No Abstract]   [Full Text] [Related]  

  • 16. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
    Gaudin P
    Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-α (TNF-α) targeted biologics and recently licensed TNF-α inhibitors: data from clinical trials and national registries.
    Cantini F; Niccoli L; Goletti D
    J Rheumatol Suppl; 2014 May; 91():56-64. PubMed ID: 24789001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of brucellosis after treatment with infliximab in a patient with rheumatoid arthritis.
    Jiménez FG; Colmenero JD; Irigoyen MV
    J Infect; 2005 May; 50(4):370-1. PubMed ID: 15845443
    [No Abstract]   [Full Text] [Related]  

  • 19. Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker.
    Agarwal PK; Gallaghar M; Murphy E; Virdi M
    Indian J Ophthalmol; 2007; 55(3):230-2. PubMed ID: 17456948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disseminated tuberculosis in patient with rheumatoid arthritis after infliximab therapy].
    Ramos González A; Corzo Delgado JE; Sánchez Bursón J
    Med Clin (Barc); 2002 Nov; 119(16):636-7. PubMed ID: 12433341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.